Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-26

Clinical Trial Update: Simvastatin Therapy for Moderate and Severe COPD [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating simvastatin therapy for moderate to severe chronic obstructive pulmonary disease was terminated with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: University of Minnesota | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 3 | Status: TERMINATED | Results posted: 2015-03-26